MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare. Notably, 41% of the Cannabis users stopped using opioids altogether.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Medicinal Marijuana Association

AUGUST 27, 2019

Together with the cell’s receptors, these compounds work to protect against many conditions as well as syndromes. The long list of medical conditions which medical cannabis helps to alleviate is all thanks to the revolutionary discoveries made by Prof. The important discoveries made by Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. Qualifying conditions for medical marijuana. percent) remains far higher than the world average (3.9

Legalization 52

Legalization Access Medicine Clinical Trials 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Pooled data analysis was performed with R programming language with R-studio platform, using “meta”, “netmeta”, “metamedian”, “metafor” 39 , 40 , 41 , 42.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

DECEMBER 22, 2021

At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. We have autism and epilepsy. Cannabis is given to oncology patients, palliative patients.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

CannaMD

AUGUST 8, 2020

Designed to treat seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome , Epidiolex is a purified (> 98% oil-based) CBD extract administered via oral spray. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD.

CBD 99

CBD DEA Research and Development Hemp 99

Puff Puff Post

DECEMBER 28, 2018

No single program or treatment is best, and specially tailored treatments based off the child’s needs are found to be most effective. They aren’t geared towards treating the condition specifically, and rather focus on reducing side-effects from the disorder like anxiety and insomnia. CBD Oil For Autism: How Can Cannabis Help?

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs. California.

Legislation 59

Legislation Patients Access Banking 59

The Cannigma

MAY 7, 2021

Europe’s obviously come a long way and most of the countries on the continent have varying degrees of medical programs alongside going hemp industries but can you start by giving a quick overview of where Europe is in comparison to North America but also your thoughts on why the momentum seems to be different?

Supply Chain 120

Supply Chain Patients Access Hemp 120

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. But what happens to the medical programs and access and probably in ways that I don’t even know what to ask? North Dakota.

Legalization 128

Legalization Patients Education Dispensary 128

SMPL

MAY 26, 2020

In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. So entrepreneurs interpreted this research-oriented pilot program as the de facto legalization of cannabidiol.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

AUGUST 12, 2019

Federally Recognized Medical Conditions. After multiphase clinical trials were completed, an FDA panel recommended approval of a CBD-based pharmaceutical called Epidiolex for treatment of certain specific and rare types of juvenile epilepsy. They should be used only as directed on the label.

CBD 40

CBD Terpenes Oil Tincture 40